Shaikh Danial Haris, Baiomi Ahmed, Mehershahi Shehriyar, Abbas Hafsa, Gongati Sudharshan, Nayudu Suresh Kumar
Division of Gastroenterology, BronxCare Hospital Center, a Clinical Affiliate of Mount Sinai Health Systems and Academic Affiliate of Icahn School of Medicine, Bronx, New York, New York, USA.
Department of Medicine, BronxCare Hospital Center, a Clinical Affiliate of Mount Sinai Health Systems and Academic Affiliate of Icahn School of Medicine, Bronx, New York, New York, USA.
Case Rep Gastroenterol. 2020 Dec 14;14(3):687-694. doi: 10.1159/000510131. eCollection 2020 Sep-Dec.
Paclitaxel, a chemotherapeutic agent, is routinely administered for the treatment of various solid organ malignancies. In rare instances, patients receiving infusions of paclitaxel may present with signs of an acute abdomen. Ischemia and necrosis of the bowel wall from chemotherapy-induced neutropenia and direct toxic effects of the drug have been implicated as the cause. We present a case of necrotizing small and large bowel perforation in a patient with breast cancer, 2 weeks after paclitaxel administration.
紫杉醇是一种化疗药物,常用于治疗各种实体器官恶性肿瘤。在罕见情况下,接受紫杉醇输注的患者可能会出现急腹症的症状。化疗引起的中性粒细胞减少导致的肠壁缺血坏死以及药物的直接毒性作用被认为是病因。我们报告一例乳腺癌患者在使用紫杉醇两周后出现坏死性小肠和大肠穿孔的病例。